Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.35 -2.22% 15.40 15.00 15.80 16.25 15.40 15.75 415,671 13:44:30
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -11.1 -4.4 - 38

Futura Medical Share Discussion Threads

Showing 16951 to 16975 of 19475 messages
Chat Pages: Latest  683  682  681  680  679  678  677  676  675  674  673  672  Older
DateSubjectAuthorDiscuss
04/7/2019
09:13
ohh... if everything goes to plan over the next few years that forecast will be VERY conservative :-)
ragnarr
04/7/2019
08:48
Each med dose cost 25 cents. Each med dose $5 retail x number of doses each man takes a year = big numbers. "Most of today's licensing agreements are based on the payment of a royalty to the licensor by the licensee. The royalty is a percentage based on a sales price of the goods (the wholesale price if the product is sold at wholesale and the retail price if it is sold at retail.)" According to the last report by Singer,Futura is expected to get a 15% royalty rate. That is on top of $90 million in upfront and milestone payments. Liberum's 140p forecast could yet look rather conservative.
j777j
03/7/2019
15:41
300 million men worldwide and counting.
j777j
03/7/2019
15:30
Up to half of men under 50 suffer from erectile dysfunction, research claims https://www.independent.co.uk/news/health/erectile-dysfunction-impotence-rates-viagra-causes-heart-disease-research-a8985216.html
keifer derrin
03/7/2019
13:31
note to self - spell check!
ragnarr
03/7/2019
13:30
I think we ate past the stage of gamble - even if Med2005 doesnt come off (although looking increasingly unlikely) there is still TPR100 that has been submitted for marketing approval.Ss a very regular user of Volterol due to a chronic back condition the option of a faster reacting gell with a larger dose of diclofenic (1.16% vs 1.86%) is an absolute no btainer The Global market for this type of pain relaif (NAISDs) is 2.9 billion USD.
ragnarr
03/7/2019
11:54
"Thats why Investors should never invest in early stage pharma stock ony in those who have already phase 3 programs ongoing and are close to clinical results if you like to make money." What a nonsense. Without early stage investors there wouldn't be any Phase III programs to back
markacus
03/7/2019
11:44
major breakout to 50p and higher could start anytime now
bioking
03/7/2019
09:03
Getting into heady territory now.Approval add a zero at the end, failure take a zero off the end. High stakes but..........GLA
jerseymike
03/7/2019
08:47
buyout or big partner deal BEFORE phase 3 readout still possible = £1++ soon .Potential BEST ED drug out there for a long time
bioking
03/7/2019
08:23
lets see if it can break the 40p and get to the next 50p barrier - its not a matter of if - just when :-)
ragnarr
03/7/2019
06:29
What an opportunity that was. Especially when the Ceo two days ago said they have had "Huge interest." Then look at the Almost $13 billion marketplaces they are addressing,with the med and pain gels. Another judge of success to me, will be when the share price exceeds the 90p all time highs set back in 2016,therefore redeeming all long term shareholders. Given Liberum's maximum success scenario of 140p,90p is quite achievable. So hopefully everyone at least gets their money back.
j777j
03/7/2019
00:31
LONDON (Alliance News) - Shares in Futura Medical PLC plunged on Friday after it said that it raised GBP5.6 million via a share placing, subscription and an open offer at a discounted price. The company placed 80 million shares at 7 pence, a 28% discount to the closing price of 9.65p on Thursday. The new shares represent 37% of the company's enlarged share capital. Shares were trading down 27% at 7.00p, on Friday. On Thursday, Futura had said it would raise GBP6 million via an accelerated bookbuild and open offer, so it missed this mark by GBP400,000. The company had said it would issue at least 71.4 million shares. Just thought I'd have a go at repeating something too as that seems to be what goes on around here. Just for those who might have forgotten, although it wasn't that long ago. :-)
glavey
02/7/2019
21:46
Was looking back at previous newsflow where FUM presented at Nov 18 annual SMSNA meeting. The 2019 annual meeting is 23-27th Oct and could present an opportunity for the update. Would certainly be a great platform for this potential game changer.
k8 rhm
02/7/2019
13:23
Just bought some more at .3915 but as usual showing as a sell. onwards and upwards.
duwendag
02/7/2019
13:15
There is even a chance we could get results in November.June last patient recruited3.months trial so sep.One month to analyse data Oct.Gla.
j777j
02/7/2019
13:12
slaccs , in the last couple of years we were in early stage of the MED program now we are just 3 or 4 months away from Phase 3 readout its now different time . Thats why Investors should never invest in early stage pharma stock ony in those who have already phase 3 programs ongoing and are close to clinical results if you like to make money.
bioking
02/7/2019
12:53
I only post what I find and at the moment Liberum see 140p upside based on very conservative numbers. The $90 million upfront and milestone payments were from former house broker Singer N+1 and it is they who also forecast at 15% royalty rate. I am waiting for the share price to return to 56p as next level,which is pretty close to Liberum's 60p.
j777j
02/7/2019
12:42
J777J - Any chance of some evidence behind all of your ramping or are you JB? Because nothing he has said in the last couple of years has ever come to anything. Just empty promise after empty promise. I would love for someone to prove me wrong.
slaccs
02/7/2019
12:29
bg23 - at times by selling I did not want to miss a potential opportunity and at other times the value of my shares was so small it was barely worth selling. In recent weeks I've had a few small but successful spreadbets. I'm sticking at the moment. We'll both be happy if it makes 48p!
2cbg
02/7/2019
11:41
A stock like FUM with close Phase 3 readout for a potential Blockbuster would be valued closer to $500 million by now in USA . Its unbelievable that FUM is still valued less than 100 million the upfront payment from a potential partner alone could be in that level .I still think buyout is more likely because its cheaper than to pay high royalties and milestones . LOVE IT
bioking
02/7/2019
11:29
2cbg.......... wd, is that foresight or pig-headed stubbornness?? I need 48p and I can tell you ahead of time it is 'outright stubbornness' !! your big decision now is surely, 'cut and run' or 'believe'.......not sure where I stand on that !! although I do feel a little silly ignoring the recent research and not adding, but then again I didn't take part in the fundraising earlier this year which was a little foolish. good luck whatever you decide
bg23
02/7/2019
11:12
I totally agree SOLis - JB needs to smile and learn some presentation skills. Anyway, after 3 years in FUM I finally broke even today!!
2cbg
02/7/2019
10:38
Must be on the radar of biofunds across the pond.
j777j
02/7/2019
10:19
large trade in the states (famdf)
mikethebike4
Chat Pages: Latest  683  682  681  680  679  678  677  676  675  674  673  672  Older
ADVFN Advertorial
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201201 18:32:51